Maternal and perinatal outcomes in women aged 42 years or older.


Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174

Informations de publication

Date de publication:
Apr 2024
Historique:
revised: 07 09 2023
received: 12 06 2023
accepted: 12 09 2023
medline: 18 3 2024
pubmed: 30 9 2023
entrez: 30 9 2023
Statut: ppublish

Résumé

To describe maternal and fetal outcomes of pregnancies after 42 years and to compare maternal and fetal morbidities according to the conception mode; comparing pregnancies obtained spontaneously and those resulting from assisted reproductive technology (ART). This retrospective cohort study was conducted in a level 3 maternity hospital. This study covered all women, aged 42 years or older, who gave birth between January 1, 2014 and December 31, 2019. Univariate and multivariate analyses with logistic regression models were used to compare maternal and perinatal outcomes depending on conception mode: spontaneous or using ART. A sample of 532 women, including 335 spontaneous pregnancies (63%) and 147 pregnancies after ART (27.6%) were studied. Conception mode was missing for 50 (9.4%). We found increased rates not only of maternal complications such as maternal overweight and obesity, pre-eclampsia, and gestational diabetes, but also of interventions such as hospitalization during pregnancy, cesarean section, postpartum hemorrhage, and perinatal outcome like preterm birth. There were also more maternal and perinatal negative outcomes among the ART group. After multivariate analysis, pre-eclampsia was predominant in the ART group (odds ratio 0.25, 95% confidence interval 0.07-0.85, P = 0.02). While maternal and fetal risks increase for late pregnancies, there also appears to be a difference depending on the conception mode, with pregnancies resulting from ART having more pregnancy-related complications than those obtained spontaneously.

Identifiants

pubmed: 37776016
doi: 10.1002/ijgo.15160
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

298-305

Informations de copyright

© 2023 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.

Références

Cinelli H, Lelong N, Le Ray C. (INSERM: EPOPé). Enquête Nationale périnatale [Internet]. 2022 [cité 27 déc 2022]. Disponible sur: https://www.xn--epop-inserm-ebb.fr/wp-content/uploads/2022/10/ENP2021_Rapport_Octobre2022.pdf
Le Ray C, Lelong N, Cinelli H, et al. Results of the 2021 French National Perinatal Survey and trends in perinatal health in metropolitan France since 1995. J Gynecol Obstet Hum Reprod. 2022;51(10):102509.
Agence de la biomédecine. Evaluation Des résultats Des Centres d'assistance médicale à la procréation Pratiquant la fécondation in Vitro en France - Rapport National Des résultats 2017-2018. 2017.
Montan S. Increased risk in the elderly parturient. Curr Opin Obstet Gynecol. 2007;19(2):110-112.
Laopaiboon M, Lumbiganon P, Intarut N, et al. Advanced maternal age and pregnancy outcomes: a multicountry assessment. BJOG Int J Obstet Gynaecol. 2014;121:49-56.
Pinborg A, Wennerholm UB, Romundstad LB, et al. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update. 2013;19(2):87-104.
Qin J, Liu X, Sheng X, Wang H, Gao S. Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertil Steril. 2016;105(1):73-85.e1-e6.
Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287-293.e1.
Keegan DA, Krey LC, Chang HC, Noyes N. Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes. Fertil Steril. 2007;87(4):776-781.
Dodd JM, Grivell RM, Crowther CA, Robinson JS. Antenatal interventions for overweight or obese pregnant women: a systematic review of randomised trials. BJOG. 2010;117(11):1316-1326.
Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet. 2021;398(10297):341-354.
Smithson SD, Greene NH, Esakoff TF. Pregnancy outcomes in very advanced maternal age women. Am J Obstet Gynecol MFM. 2022;4(1):100491.
Paulson RJ, Boostanfar R, Saadat P, et al. Pregnancy in the sixth decade of life obstetric outcomes in women of advanced reproductive age. JAMA. 2002;288(18):2320-2323.
Salha O, Sharma V, Dada T, et al. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod Oxf Engl. 1999;14(9):2268-2273.
Omani-Samani R, Alizadeh A, Almasi-Hashiani A, et al. Risk of preeclampsia following assisted reproductive technology: systematic review and meta-analysis of 72 cohort studies. J Matern-Fetal Neonatal Med. 2020;33(16):2826-2840.
Salihu HM, Shumpert MN, Slay M, Kirby RS, Alexander GR. Childbearing beyond maternal age 50 and fetal outcomes in the United States. Obstet Gynecol. 2003;102(5 Pt 1):1006-1014.
Yogev Y, Melamed N, Bardin R, Tenenbaum-Gavish K, Ben-Shitrit G, Ben-Haroush A. Pregnancy outcome at extremely advanced maternal age. Am J Obstet Gynecol. 2010;203(6):558.e1-558.e7.
Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol. 2004;103(3):551-563.
Luke B, Brown MB. Contemporary risks of maternal morbidity and adverse outcomes with increasing maternal age and plurality. Fertil Steril. 2007;88(2):283-293.
Wiggins DA, Main E. Outcomes of pregnancies achieved by donor egg in vitro fertilization-a comparison with standard in vitro fertilization pregnancies. Am J Obstet Gynecol. 2005;192(6):2002-2006. discussion 2006-2008.

Auteurs

Maeva Landry (M)

Department of Obstetrics and Gynecology, Paule de Viguier Hospital, CHU Toulouse, France.

Mickael Allouche (M)

Department of Obstetrics and Gynecology, Paule de Viguier Hospital, CHU Toulouse, France.
CERPOP, UMR 1295, Team SPHERE (Study of Perinatal, Pediatric and Adolescent Health: Epidemiological Research and Evaluation), Toulouse III University, Toulouse, France.

Christophe Vayssière (C)

Department of Obstetrics and Gynecology, Paule de Viguier Hospital, CHU Toulouse, France.
CERPOP, UMR 1295, Team SPHERE (Study of Perinatal, Pediatric and Adolescent Health: Epidemiological Research and Evaluation), Toulouse III University, Toulouse, France.

Paul Guerby (P)

Department of Obstetrics and Gynecology, Paule de Viguier Hospital, CHU Toulouse, France.
Infinity, CNRS INSERM U1291, Toulouse III University, Toulouse, France.

Marion Groussolles (M)

CERPOP, UMR 1295, Team SPHERE (Study of Perinatal, Pediatric and Adolescent Health: Epidemiological Research and Evaluation), Toulouse III University, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH